What are the recommended pre- and post-thrombolytic management guidelines for acute myocardial infarction?

Pre and Post Thrombolytic Management in Acute Myocardial Infarction

When fibrinolysis is chosen as the reperfusion strategy for STEMI, initiate treatment as soon as possible after diagnosis (preferably pre-hospital), use a fibrin-specific agent (tenecteplase, alteplase, or reteplase), and immediately transfer all patients to a PCI-capable center following thrombolysis for angiography within 2-24 hours if successful. 1

Pre-Thrombolytic Management

Immediate Assessment and Monitoring

• Obtain 12-lead ECG within 10 minutes of first medical contact to confirm ST-segment elevation or new left bundle-branch block 1
• Initiate ECG monitoring with defibrillator capacity immediately in all suspected STEMI patients 1
• Avoid routine oxygen unless SaO₂ <90% 1

Pre-Thrombolytic Medications (Administer Simultaneously)

Antiplatelet Therapy:

• Aspirin 160-325 mg orally (chewed) or IV if unable to swallow - give as soon as possible 1, 2
• Clopidogrel loading dose in addition to aspirin 1
  • Note: Prasugrel and ticagrelor have NOT been studied with fibrinolysis and should not be used 1

Anticoagulation (Choose One):

• Enoxaparin IV bolus followed by subcutaneous (preferred over UFH) 1
• UFH as weight-adjusted IV bolus followed by infusion if enoxaparin unavailable 1
• Continue anticoagulation until revascularization or for duration of hospital stay up to 8 days 1

Thrombolytic Agent Selection:

• Use fibrin-specific agents: tenecteplase (preferred for single-bolus ease), alteplase, or reteplase 1
• For symptom duration <6 hours: alteplase superior to streptokinase 2
• Avoid streptokinase re-administration due to antibody formation 1

Critical Contraindications to Screen For

Absolute contraindications (do NOT give thrombolytics): 2

• Any history of intracranial hemorrhage
• Ischemic stroke within past 3 months
• Closed head trauma within 3 months
• Active internal bleeding
• Known intracranial neoplasm or AV malformation

Important caveat: Short successful resuscitation does NOT contraindicate fibrinolysis, but prolonged/traumatic resuscitation is a relative contraindication 1

Post-Thrombolytic Management

Immediate Post-Lysis Protocol

Assess Reperfusion Success:

• Monitor ST-segment resolution at 60-90 minutes post-thrombolysis 1
• <50% ST-segment resolution = failed thrombolysis

Transfer Strategy:

• Transfer ALL patients to PCI-capable center immediately after fibrinolysis - this is non-negotiable 1
• Patients should bypass emergency department and go directly to catheterization laboratory when indicated 1

Post-Thrombolytic Angiography Timing (Critical Algorithm)

Emergency angiography (immediate):

• Heart failure or cardiogenic shock 1
• Failed thrombolysis (<50% ST-resolution at 60-90 min) - rescue PCI indicated 1
• Hemodynamic instability at any time 1
• Electrical instability (malignant arrhythmias) 1
• Worsening ischemia 1
• Recurrent ischemia or evidence of reocclusion 1

Routine angiography (planned):

• Between 2-24 hours after successful fibrinolysis for angiography and PCI of infarct-related artery if indicated 1

This pharmacoinvasive strategy (thrombolysis followed by planned PCI) is the standard of care and improves outcomes compared to thrombolysis alone 1.

Ongoing Antithrombotic Management

Continue through hospitalization:

• Low-dose aspirin 75-100 mg daily indefinitely 1
• Clopidogrel continuation 1
• Anticoagulation (enoxaparin or UFH) until revascularization or up to 8 days 1

Additional Post-MI Therapies (Within 24 Hours)

Mandatory medications (unless contraindicated):

• ACE inhibitors within first 24 hours for patients with heart failure, LV dysfunction (EF <40%), diabetes, or anterior infarct 1
• High-intensity statin therapy started as early as possible 1
• Beta-blockers for patients with heart failure and/or LVEF <40% (avoid IV beta-blockers if hypotension, acute heart failure, or AV block) 1

Target LDL-C <1.8 mmol/L (70 mg/dL) or ≥50% reduction if baseline 1.8-3.5 mmol/L 1

Monitoring for Complications

Routine echocardiography during hospital stay to assess: 1

• LV and RV function
• Early mechanical complications
• LV thrombus

Long-Term Management (Post-Discharge)

Dual antiplatelet therapy (DAPT) for 12 months:

• Aspirin 75-100 mg + clopidogrel (since prasugrel/ticagrelor not studied with fibrinolysis) 1
• Add PPI if high gastrointestinal bleeding risk 1

Consider MRA (mineralocorticoid receptor antagonist) if EF <40% with heart failure or diabetes, already on ACE inhibitor and beta-blocker, without renal failure or hyperkalemia 1

Cardiac rehabilitation program participation 1

Key Pitfalls to Avoid

1. Do NOT use fondaparinux for patients proceeding to primary PCI 1
2. Do NOT use GP IIb/IIIa inhibitors with fibrinolysis - increases bleeding without benefit 1
3. Do NOT delay transfer to PCI center after thrombolysis - all patients need transfer regardless of apparent success 1
4. Do NOT perform routine PCI of occluded infarct-related artery >48 hours after STEMI onset in asymptomatic patients 1
5. Do NOT use IV beta-blockers acutely if hypotension, heart failure, or bradycardia present 1

The evidence strongly supports this pharmacoinvasive approach, with the 2017 ESC Guidelines 1 providing the most comprehensive and recent framework. The critical concept is that thrombolysis is a bridge to definitive mechanical reperfusion, not a standalone therapy in the modern era.